Comparisons

AOD-9604 vs Semaglutide vs Tirzepatide Compared

AOD-9604, semaglutide and tirzepatide are three of the most searched peptides in the metabolic research space, and they are frequently grouped together even though they belong to very different chemical families. This guide breaks down what separates them, how each is classified, and where they sit in current research literature, without the marketing spin you find elsewhere.

Three peptides, three mechanisms

The most important thing to understand is that these compounds do not share a common pathway. Lumping them into a single “fat loss peptide” bucket obscures how differently they behave at the molecular level.

  • AOD-9604 is a modified fragment of human growth hormone. It corresponds to the C-terminal region (residues 176-191) of the hGH molecule, engineered so that it is studied for its effect on lipid metabolism without the full growth-signalling activity of intact growth hormone.
  • Semaglutide is a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, an incretin hormone involved in glucose regulation and satiety signalling. It is a single-pathway agonist.
  • Tirzepatide is a dual agonist. It activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, which is why it is often described as a “twincretin.”

Comparison at a glance

Property AOD-9604 Semaglutide Tirzepatide
Class hGH fragment (176-191) GLP-1 agonist GLP-1 / GIP dual agonist
Origin Growth hormone peptide Incretin analogue Incretin analogue
Receptor targets Lipid metabolism pathways GLP-1 receptor GLP-1 + GIP receptors
Molecule size Small (16 amino acids) Larger, acylated Larger, acylated
Research focus Lipolysis, cartilage Glycaemic, appetite Glycaemic, appetite

AOD-9604 in detail

Because AOD-9604 is a short fragment rather than a full hormone or a large engineered analogue, it is the structurally simplest of the three. Research interest has centred on its interaction with fat metabolism and, separately, on cartilage and connective-tissue models. It does not act on the incretin system at all, which is the single clearest point of difference from the other two compounds. Anyone treating AOD-9604 as interchangeable with a GLP-1 drug is comparing molecules that share almost nothing beyond a broad research theme.

Semaglutide vs tirzepatide

Semaglutide and tirzepatide are much closer relatives. Both are large, acylated incretin analogues designed for extended activity, and both are studied primarily in the context of glucose handling and appetite pathways. The defining distinction is receptor coverage: semaglutide engages GLP-1 alone, while tirzepatide adds GIP receptor activity. That dual mechanism is the reason tirzepatide is studied as a distinct next-generation compound rather than simply a stronger version of semaglutide.

How to think about them

If you are researching these compounds, the practical takeaway is that AOD-9604 sits on one side of a clear line (a growth-hormone-derived peptide) while semaglutide and tirzepatide sit on the other (incretin analogues). Choosing between the incretin pair comes down to single versus dual receptor activity. None of the three is a substitute for another, and reputable comparisons treat them as separate research tools rather than ranked alternatives.

Why they get grouped together

The reason these three names keep appearing side by side is search behaviour, not shared biology. Because all three are studied in connection with metabolism and body composition, they collide in the same conversations and product listings. That overlap is superficial. AOD-9604 came out of growth-hormone research, while semaglutide and tirzepatide came out of incretin and glucose-regulation research, two distinct scientific lineages. Reading a comparison that treats them as three flavours of one product is a sign the source has not looked past the marketing. The mechanisms, the receptor targets and the molecular sizes all tell you these are separate tools that happen to share a research theme.

For definitions of terms like agonist, fragment and reconstitution, our peptide guide covers the fundamentals in plain language.

Sourcing peptides in Canada

LYFE Science is a Canadian supplier shipping nationwide by Canada Post, with flat $25 shipping and free delivery on orders over $150. Orders paid before noon ET dispatch the same day and reach most of Canada in 1-3 business days, in neutral packaging. Every lot is checked by HPLC and mass spectrometry, with a COA available on request. We accept Interac e-Transfer and crypto (BTC, ETH, SOL, USDC, USDT).

Browse the current catalogue and check availability below.

Buy research peptides in Canada

Follow along

Research, lab-side

@lyfe_science →